1. Epidermolysis bullosa: developing drugs for treatment of cutaneous manifestations Publication: Silver Spring, MD : Center for Drug Evaluation and Research, June 2019 Subject(s): Epidermolysis Bullosa -- drug therapySkin ManifestationsClinical Trials as TopicResearch DesignHumansUnited StatesUnited States. Department of Health and Human Services.United States. Food and Drug Administration.
